99 related articles for article (PubMed ID: 1448470)
1. Further evidence for enigmas in adaptation mechanisms for the DOI-induced behaviors.
Darmani NA
Pharmacol Biochem Behav; 1992 Nov; 43(3):765-70. PubMed ID: 1448470
[TBL] [Abstract][Full Text] [Related]
2. Behavioral evidence for differential adaptation of the serotonergic system after acute and chronic treatment with (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) or ketanserin.
Darmani NA; Martin BR; Glennon RA
J Pharmacol Exp Ther; 1992 Aug; 262(2):692-8. PubMed ID: 1501117
[TBL] [Abstract][Full Text] [Related]
3. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI.
Darmani NA; Gerdes CF
Pharmacol Biochem Behav; 1995 Apr; 50(4):545-50. PubMed ID: 7617700
[TBL] [Abstract][Full Text] [Related]
4. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
Darmani NA; Mock OB; Towns LC; Gerdes CF
Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
[TBL] [Abstract][Full Text] [Related]
5. Role of the inhibitory adrenergic alpha 2 and serotonergic 5-HT1A components of cocaine's actions on the DOI-induced head-twitch response in 5-HT2-receptor supersensitive mice.
Darmani NA
Pharmacol Biochem Behav; 1993 Jun; 45(2):269-74. PubMed ID: 8392199
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
Darmani NA
Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
[TBL] [Abstract][Full Text] [Related]
7. Differential ontogenesis of three DOI-induced behaviors in mice.
Darmani NA; Shaddy J; Gerdes CF
Physiol Behav; 1996 Dec; 60(6):1495-500. PubMed ID: 8946497
[TBL] [Abstract][Full Text] [Related]
8. The effects of acute cocaine administration on the DOI-induced head-twitch response in reserpinized mice.
Darmani NA
Pharmacol Biochem Behav; 1994 Sep; 49(1):229-32. PubMed ID: 7816879
[TBL] [Abstract][Full Text] [Related]
9. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Darmani NA; Martin BR; Glennon RA
Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
[TBL] [Abstract][Full Text] [Related]
10. [Serotonergic mechanisms of hippocampal kindled seizures in cats--effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and ketanserin].
Nakamura M; Wada Y; Hasegawa H; Yamaguchi N
No To Shinkei; 1993 Oct; 45(10):935-9. PubMed ID: 8268033
[TBL] [Abstract][Full Text] [Related]
11. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
12. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin.
Krebs-Thomson K; Lehmann-Masten V; Naiem S; Paulus MP; Geyer MA
Eur J Pharmacol; 1998 Feb; 343(2-3):135-43. PubMed ID: 9570460
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
Yasuda K; Suemaru K; Araki H; Gomita Y
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711
[TBL] [Abstract][Full Text] [Related]
14. 2,5-Dimethoxy-4-iodoamphetamine (DOI) inhibits Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Koushi E; Mishima K; Iwasaki K; Oishi R; Fujiwara M
J Pharmacol Sci; 2007 Dec; 105(4):361-6. PubMed ID: 18057774
[TBL] [Abstract][Full Text] [Related]
15. 5-HT2 receptors, roles and regulation.
Leysen JE; Pauwels PJ
Ann N Y Acad Sci; 1990; 600():183-91; discussion 192-3. PubMed ID: 2252309
[TBL] [Abstract][Full Text] [Related]
16. Withdrawal from chronic treatment with (+/-)-DOI causes super-sensitivity to 5-HT2 receptor-induced head-twitch behaviour in mice.
Darmani NA; Martin BR; Glennon RA
Eur J Pharmacol; 1990 Sep; 186(1):115-8. PubMed ID: 2282932
[TBL] [Abstract][Full Text] [Related]
17. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
Johansson-Wallsten CE; Berg M; Meyerson BJ
Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of ear-scratch response in mice as a behavioral model for selective 5-HT2-receptor agonists and evidence for 5-HT1B- and 5-HT2-receptor interactions.
Darmani NA; Martin BR; Pandey U; Glennon RA
Pharmacol Biochem Behav; 1990 Sep; 37(1):95-9. PubMed ID: 2263671
[TBL] [Abstract][Full Text] [Related]
19. Serotonin2 (5-HT2) receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) inhibits chlorpromazine- and haloperidol-induced hypothermia in mice.
Yamada J; Sugimoto Y; Horisaka K
Biol Pharm Bull; 1995 Nov; 18(11):1580-3. PubMed ID: 8593484
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
Chaouloff F; Baudrie V; Coupry I
Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
